Showing 1230 – 1240 of 1304 results
-
Alto Neuroscience Inc Initiation
William Blair initiated research coverage of Alto Neuroscience, Inc. (ANRO $13.72), a company focused on developing novel therapies for high-unmet-need indications in psychiatry supported by AI-enabled precision approaches to identify response biomarkers.
-
First Advantage Corporation Initiation
William Blair initiated research coverage of First Advantage Corporation (FA $15.32), a leading global provider of technology-enabled background screening products.
-
Tradeweb Markets Inc Initiation
William Blair initiated research coverage of Tradeweb Markets Inc. (TW $102.40), a leading operator of electronic marketplaces for rates, credit, equities, and money markets, with a focus on fixed income.
-
Kenvue Inc Initiation
William Blair initiated research coverage of Kenvue Inc. (KVUE $20.82), a global leader at the intersection of consumer goods and healthcare.
-
Vital Farms Inc Initiation
William Blair initiated research coverage of Vital Farms, Inc. (VITL $24.71), an ethically minded food company that is disrupting the U.S. food system.
-
Pinstripes Holdings Inc Initiation
William Blair initiated research coverage of Pinstripes Holdings, Inc. (PNST $2.95), a high-volume dining and entertainment brand that combines scratch-made Italian American cuisine with entertainment offerings such as bowling, bocce, and private event spaces.
-
On Holding AG Initiation
William Blair initiated research coverage of On Holding AG (ONON $32.87), a fast-growing performance and lifestyle brand based in Switzerland selling athletic footwear, primarily in running, but with a growing presence in newer categories and apparel.
-
Cullinan Oncology Inc Initiation
William Blair initiated research coverage of Cullinan Oncology, Inc. (CGEM $17.37), a company focused on advancing modality-agnostic targeted therapies for cancer, with a broad pipeline encompassing small molecules and multifunctional therapies across a diverse range of oncologic targets.
-
LENZ Therapeutics Inc Initiation
William Blair initiated research coverage of LENZ Therapeutics, Inc. (LENZ $21.73), a late-stage clinical company developing ophthalmic pharmaceutical products to improve vision.
-
William Blair Initiates Coverage of Four Companies in the Lithium-Ion Battery Industry
William Blair initiated research coverage of Enovix Corporation, Amprius Technologies, Inc., SES AI Corporation, and QuantumScape Corporation.